MedKoo Cat#: 462258 | Name: UK-101

Description:

WARNING: This product is for research use only, not for human or veterinary use.

UK-101 is a potent and selective immunoproteasome β1i (LMP2) inhibitor. UK-101 induces cell apoptosis and can be used for the study of prostate cancer.

Chemical Structure

UK-101
UK-101
CAS#1000313-40-5

Theoretical Analysis

MedKoo Cat#: 462258

Name: UK-101

CAS#: 1000313-40-5

Chemical Formula: C25H48N2O5Si

Exact Mass: 484.3332

Molecular Weight: 484.75

Elemental Analysis: C, 61.94; H, 9.98; N, 5.78; O, 16.50; Si, 5.79

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
UK-101; UK101; UK 101
IUPAC/Chemical Name
N-((S)-1-(((S)-1-((S)-2-(((tert-butyldimethylsilyl)oxy)methyl)oxiran-2-yl)-4-methyl-1-oxopentan-2-yl)amino)-1-oxopropan-2-yl)heptanamide
InChi Key
OHYPIFPQEYUPDQ-RLSLOFABSA-N
InChi Code
InChI=1S/C25H48N2O5Si/c1-10-11-12-13-14-21(28)26-19(4)23(30)27-20(15-18(2)3)22(29)25(16-31-25)17-32-33(8,9)24(5,6)7/h18-20H,10-17H2,1-9H3,(H,26,28)(H,27,30)/t19-,20-,25-/m0/s1
SMILES Code
CCCCCCC(N[C@H](C(N[C@H](C([C@]1(CO1)CO[Si](C)(C(C)(C)C)C)=O)CC(C)C)=O)C)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 484.75 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: de Bruin G, Huber EM, Xin BT, et al. Structure-based design of β1i or β5i specific inhibitors of human immunoproteasomes. J Med Chem. 2014;57(14):6197-6209. doi:10.1021/jm500716s 2: Wehenkel M, Ban JO, Ho YK, Carmony KC, Hong JT, Kim KB. A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice. Br J Cancer. 2012;107(1):53-62. doi:10.1038/bjc.2012.243